Table 2

Effect of nonspecific binding on the determination of in vitro Ki values of fluvoxamine toward CYP2C19

SystemProtein Conc.Ki,totalFree Fraction2-aKi,ub
mg/ml nM f u,mic nM
HLM1400  ± 370.20  ± 0.0580
HLM0.5226  ± 190.31  ± 0.0370
Supersomes0.1596  ± 140.81  ± 0.0378

Supersomes, cDNA-expressed CYP2C19.

  • 2-a Fluvoxamine spiked concentration was 0.3 μM.